ProQR Therapeutics N.V. (PRQR)

NASDAQ: PRQR · IEX Real-Time Price · USD

1.33

-0.05 (-3.62%)

Sep 28, 2023, 4:00 PM EDT - Market closed

Income Statement (Annual)

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Revenue	4.8	2.4	9.45	1.93	5.76	1.5	1.83	3.24	0.31	0.12
Revenue Growth (YoY)	100.33%	-74.64%	388.98%	-66.45%	285.35%	-18.22%	-43.49%	933.55%	169.83%	-
Gross Profit	4.8	2.4	9.45	1.93	5.76	1.5	1.83	3.24	0.31	0.12
Selling, General & Admin	18.65	17.37	13.69	12.89	12.54	10.84	9.48	6.84	6.51	0.79
Research & Development	50.87	42.22	38.14	46.49	29.51	31.15	31.92	23.4	10.27	2.57
Operating Expenses	69.52	59.59	51.82	59.38	42.05	41.99	41.4	30.24	16.77	3.36
Operating Income	-64.72	-57.19	-42.37	-57.45	-36.29	-40.5	-39.57	-27	-16.46	-3.24
Interest Expense / Income	5.13	3.41	4.03	1.08	0.79	3.18	-0.47	-6.17	-4.33	0.01
Other Expense / Income	-4.83	0.91	0.04	-2.18	-0.19	-0.04	-	-	-	-
Pretax Income	-65.02	-61.5	-46.44	-56.35	-36.89	-43.64	-39.1	-20.83	-12.13	-3.25
Income Tax	0.1	0.12	0.12	0.13	0	0	0	0	0	0
Net Income	-65.11	-61.62	-46.57	-56.48	-36.89	-43.64	-39.1	-20.83	-12.13	-3.25
Shares Outstanding (Basic)	72	64	50	41	34	25	23	23	11	6
Shares Outstanding (Diluted)	72	64	50	41	34	25	23	23	11	6
Shares Change	11.62%	28.21%	21.99%	20.51%	34.20%	8.69%	0.01%	110.63%	100.86%	-
EPS (Basic)	-0.91	-0.96	-0.93	-1.38	-1.08	-1.72	-1.67	-0.89	-1.09	-0.59
EPS (Diluted)	-0.91	-0.96	-0.93	-1.38	-1.08	-1.72	-1.67	-0.89	-1.09	-0.59
Free Cash Flow	-65.46	-24.08	-47	-45.17	-28.93	-35.22	-36.76	-25.53	-15.57	-2.47
Free Cash Flow Per Share	-0.91	-0.38	-0.94	-1.10	-0.85	-1.39	-1.57	-1.09	-1.41	-0.45
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-1347.69%	-2385.94%	-448.24%	-2971.81%	-629.98%	-2708.90%	-2164.82%	-834.71%	-5259.11%	-2792.24%
Profit Margin	-1355.91%	-2570.76%	-492.65%	-2921.88%	-640.41%	-2918.86%	-2139.11%	-643.96%	-3874.44%	-2804.31%
Free Cash Flow Margin	-1363.22%	-1004.42%	-497.21%	-2336.83%	-502.24%	-2355.65%	-2010.94%	-789.12%	-4973.16%	-2128.45%
EBITDA	-57.37	-55.77	-40.06	-53.21	-35.11	-39.4	-38.33	-26.52	-16.34	-3.22
EBITDA Margin	-1194.65%	-2326.66%	-423.79%	-2752.87%	-609.43%	-2635.12%	-2096.72%	-819.88%	-5218.85%	-2771.55%
Depreciation & Amortization	2.52	2.33	2.36	2.05	0.99	1.07	1.25	0.48	0.13	0.02
EBIT	-59.89	-58.1	-42.41	-55.27	-36.1	-40.46	-39.57	-27	-16.46	-3.24
EBIT Margin	-1247.15%	-2423.82%	-448.71%	-2859.03%	-626.64%	-2706.35%	-2164.82%	-834.71%	-5259.11%	-2792.24%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).